HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An ex vivo perfused ventilated murine lung model suggests lack of acute pulmonary toxicity of the potential novel anticancer agent (-)-englerin A.

Abstract
(-)-Englerin A (EA), a potential novel anti-cancer drug, is a potent selective activator of classical transient receptor potential 4 and 5 (TRPC4, TRPC5) channels. As TRPC4 channels are expressed and functional in the lung endothelium, possible side effects such as lung edema formation may arise during its administration. Well-established in vivo rodent models for toxicological testing, however, rapidly degrade this compound to its inactive derivative, englerin B. Therefore, we chose an ex vivo isolated perfused and ventilated murine lung (IPVML) model to detect edema formation due to toxicants, which also reduces the number of incriminating animal experiments required. To evaluate the sensitivity of the IPVML model, short-time (10 min) drops of the pH from 7.4 down to 4.0 were applied, which resulted in linear changes of tidal volumes, wet-to-dry weight ratios and incorporation of FITC-coupled dextran particles from the perfusate. As expected, biological activity of EA was preserved after perfusion in the IPVML model. Concentrations of 50-100 nM EA continuously perfused through the IPVML model did not change tidal volumes and lung weights significantly. Wet-to-dry weight ratios were increased after perfusion of 100 nM EA but permeation of FITC-coupled dextran particles from the perfusate to the lung tissues was not significantly different. Therefore, EA shows little or no significant acute pulmonary toxicity after application of doses expected to activate target ion channels and the IPVML is a sensitive powerful ex vivo model for evaluating acute lung toxicity in accordance with the 3R rules for animal experimentation.
AuthorsChristian Schremmer, Dirk Steinritz, Thomas Gudermann, David J Beech, Alexander Dietrich
JournalArchives of toxicology (Arch Toxicol) Vol. 96 Issue 4 Pg. 1055-1063 (04 2022) ISSN: 1432-0738 [Electronic] Germany
PMID35165752 (Publication Type: Journal Article)
Copyright© 2022. The Author(s).
Chemical References
  • Antineoplastic Agents
  • Dextrans
  • Sesquiterpenes, Guaiane
  • TRPC Cation Channels
  • englerin A
  • Fluorescein-5-isothiocyanate
Topics
  • Animals
  • Antineoplastic Agents (toxicity)
  • Dextrans (metabolism)
  • Edema
  • Fluorescein-5-isothiocyanate
  • Lung (metabolism)
  • Mice
  • Perfusion
  • Sesquiterpenes, Guaiane
  • TRPC Cation Channels (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: